Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
Abstract Idiopathic pulmonary fibrosis (IPF) represents a clinical and therapeutic challenge characterized by progressive fibrosis and destruction of the lung architecture. The pathogenesis of IPF has been long debated; while it is generally believed that repeated lung injury and abnormal wound repa...
Saved in:
| Main Authors: | Giacomo Giulianelli, Elisabetta Cocconcelli, Giordano Fiorentù, Nicol Bernardinello, Elisabetta Balestro, Paolo Spagnolo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-05-01
|
| Series: | Pulmonary Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s41030-025-00296-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review
by: Maria Conti, et al.
Published: (2025-07-01) -
Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portrait
by: Nicol Bernardinello, et al.
Published: (2025-06-01) -
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series
by: Maria Angela Licata, et al.
Published: (2025-04-01) -
Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into non-typeable Haemophilus influenza pathogenesis
by: Anthony Shadid, et al.
Published: (2024-12-01) -
The impact of the COVID-19 pandemic on the profile of interstitial lung disease presenting to the pulmonary medicine department of a tertiary care center in western India
by: Unnati Desai, et al.
Published: (2025-03-01)